NCT06908356Phase 2Recruiting

An Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic Seizures

Study sponsor: Praxis Precision Medicines

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-07Estimated
Enrollment · participants50Estimated
Source updated2025-04-03Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.